OTHER INFORMATION
−Removed: None of our directors or officers have ado pted , modified, or termi nated any trading plans under Rule 10b5-1 of the Exchange Act or any similar arrangements during the six months ended June 30, 2024.
+Added: None of our directors or officers have ado pted , modified, or termi nated any trading plans under Rule 10b5-1 of the Exchange Act or any similar arrangements during the nine months ended September 30, 2024.
The exhibits listed in the accompanying index to exhibits are filed or incorporated by reference as part of this Quarterly Report.
17 unchanged sentences
Acurx Pharmaceuticals, Inc.
−Removed: August 8, 2024
+Added: November 12, 2024
President and Chief Executive Officer
(Principal Executive Officer)
−Removed: August 8, 2024
+Added: November 12, 2024
/s/ Robert G.
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.